Literature DB >> 12824062

Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease.

Yan Ling1, Kevin Morgan, Noor Kalsheker.   

Abstract

The processing of amyloid precursor protein (APP) generates amyloid-beta (Abeta) peptides 1-40 and 1-42. The latter is neurotoxic and its accumulation results in amyloid fibril formation and the generation of senile plaques, the hallmark of Alzheimer's disease (AD). Whilst there has been considerable progress made in understanding the generation of Abeta by alpha-, beta- and gamma-secretase activity on APP, recently enzymes involved in the degradation of Abeta have been identified including neprilysin and insulin-degrading enzyme (IDE). We review the pathways involved in proteolytic processing of APP and discuss the potential implications of aberrant proteolysis on neurodegeneration. It is conceivable that single nucleotide polymorphisms (SNPs) in the regulatory regions of genes in these proteolytic cascades, which alter their expression, could contribute to some of the age-related changes seen in AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824062     DOI: 10.1016/s1357-2725(03)00133-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  41 in total

Review 1.  The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

Authors:  Anna M Barron; Giuseppe Verdile; Ralph N Martins
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5×FAD Transgenic Mice.

Authors:  Kunmu Zheng; Xiaoman Dai; Nai'an Xiao; Xilin Wu; Zhen Wei; Wenting Fang; Yuangui Zhu; Jing Zhang; Xiaochun Chen
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

3.  A proteomic approach for the involvement of the GAPDH in Alzheimer disease in the blood of Moroccan FAD cases.

Authors:  Nadia El Kadmiri; Raquel Cuardos; Bouchra El Moutawakil; Ilham Slassi; Jesus Avila; Sellama Nadifi; Ahmed Hachem; Abdelaziz Soukri
Journal:  J Mol Neurosci       Date:  2014-07-15       Impact factor: 3.444

4.  Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

Authors:  Liang-Jun Yan; Ming Xiao; Ran Chen; Zhiyou Cai
Journal:  Aging Neurodegener       Date:  2013-08

Review 5.  Tailoring of membrane proteins by alternative splicing of pre-mRNA.

Authors:  Kathleen F Mittendorf; Catherine L Deatherage; Melanie D Ohi; Charles R Sanders
Journal:  Biochemistry       Date:  2012-06-29       Impact factor: 3.162

6.  Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease.

Authors:  Jing Lin; Xian Li; Fangping Yuan; Ling Lin; Christine L Cook; Ch V Rao; Zhenmin Lei
Journal:  J Neuropathol Exp Neurol       Date:  2010-03       Impact factor: 3.685

7.  Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinase.

Authors:  Diana W Shineman; Aleksandra S Dain; Minkyu L Kim; Virginia M-Y Lee
Journal:  Biochemistry       Date:  2009-05-05       Impact factor: 3.162

8.  Tetrahydroxy stilbene glucoside reduces the cognitive impairment and overexpression of amyloid precursor protein induced by aluminum exposure.

Authors:  Hong-Bo Luo; Jin-Sheng Yang; Xiang-Qun Shi; Xue-Feng Fu; Qi-Dong Yang
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

Review 9.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

Review 10.  Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease.

Authors:  J Steven Jacobsen; Peter Reinhart; Menelas N Pangalos
Journal:  NeuroRx       Date:  2005-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.